AU Patent

AU2016311426B2 — Compounds and compositions useful for treating disorders related to NTRK

Assigned to Blueprint Medicines Corp · Expires 2021-05-20 · 5y expired

What this patent protects

This invention relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants.

USPTO Abstract

This invention relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016311426B2
Jurisdiction
AU
Classification
—
Expires
2021-05-20
Drug substance claim
No
Drug product claim
No
Assignee
Blueprint Medicines Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.